Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Ritter

Showing results (71-80 of 195) with videos related to

Pageof 20
Sort By:
Frontiers in Oncology|June 1, 2022
RNA Sequencing Reveals Alterations and Similarities in Cell Metabolism, Hypoxia and Immune Evasion in Primary Cell Cultures of Clear Cell Renal Cell CarcinomaAdrian Georg Simon, Laura Kristin Esser, Jörg Ellinger, et al.
World Journal of Urology|November 26, 2021
A prospective study on inter-operator variability in semi-robotic software-based MRI/TRUS-fusion targeted prostate biopsiesFabian Derigs, Samuel Doryumu, Fabian Tollens, et al.
European Urology Oncology|November 23, 2023
On-treatment Modified Glasgow Prognostic Score Provides Predictive Information Complementary to Radiological Staging in Metastatic Urothelial Carcinoma on ImmunotherapyJonas Saal, Viktor Grünwald, Tobias Bald, et al.
Cureus|February 27, 2024
Ring Finger Protein 34 (RNF34) as a Prognostic Biomarker for Clear Cell Renal Cell CarcinomaJohannes Stein, Niklas Klümper, Pirmin Zöhrer, et al.
JAMA Oncology|June 22, 2023
Integrating On-Treatment Modified Glasgow Prognostic Score and Imaging to Predict Response and Outcomes in Metastatic Renal Cell CarcinomaJonas Saal, Tobias Bald, Markus Eckstein, et al.
BJU International|January 28, 2020
The N<sup>6</sup> -methyladenosine (m<sup>6</sup> A) erasers alkylation repair homologue 5 (ALKBH5) and fat mass and obesity-associated protein (FTO) are prognostic biomarkers in patients with clear cell renal carcinomaAlexander Strick, Felix von Hagen, Larissa Gundert, et al.
Molecular Carcinogenesis|March 23, 2021
N<sup>6</sup> -Methyladenosine (m<sup>6</sup> A) readers are dysregulated in renal cell carcinomaFelix von Hagen, Larissa Gundert, Alexander Strick, et al.
Trends in Parasitology|September 4, 2025
Mansonella perstans - the forgotten filariaManuel Ritter, Hsun Yun Hsu, Benjamin Lenz, et al.
Urologic Oncology|May 21, 2020
The contrasting roles of Dysferlin during tumor progression in renal cell carcinomaAlexander Cox, Chenming Zhao, Yuri Tolkach, et al.
European Urology|September 30, 2019
Multiparametric Cystoscopy for Detection of Bladder Cancer Using Real-time Multispectral ImagingMaximilian C Kriegmair, Jan Rother, Bartłomiej Grychtol, et al.
Pageof 20

Showing results (71-80 of 195) with videos related to

Sort By:
Pageof 20
Frontiers in Oncology|June 1, 2022
RNA Sequencing Reveals Alterations and Similarities in Cell Metabolism, Hypoxia and Immune Evasion in Primary Cell Cultures of Clear Cell Renal Cell CarcinomaAdrian Georg Simon, Laura Kristin Esser, Jörg Ellinger, et al.
World Journal of Urology|November 26, 2021
A prospective study on inter-operator variability in semi-robotic software-based MRI/TRUS-fusion targeted prostate biopsiesFabian Derigs, Samuel Doryumu, Fabian Tollens, et al.
European Urology Oncology|November 23, 2023
On-treatment Modified Glasgow Prognostic Score Provides Predictive Information Complementary to Radiological Staging in Metastatic Urothelial Carcinoma on ImmunotherapyJonas Saal, Viktor Grünwald, Tobias Bald, et al.
Cureus|February 27, 2024
Ring Finger Protein 34 (RNF34) as a Prognostic Biomarker for Clear Cell Renal Cell CarcinomaJohannes Stein, Niklas Klümper, Pirmin Zöhrer, et al.
JAMA Oncology|June 22, 2023
Integrating On-Treatment Modified Glasgow Prognostic Score and Imaging to Predict Response and Outcomes in Metastatic Renal Cell CarcinomaJonas Saal, Tobias Bald, Markus Eckstein, et al.
BJU International|January 28, 2020
The N<sup>6</sup> -methyladenosine (m<sup>6</sup> A) erasers alkylation repair homologue 5 (ALKBH5) and fat mass and obesity-associated protein (FTO) are prognostic biomarkers in patients with clear cell renal carcinomaAlexander Strick, Felix von Hagen, Larissa Gundert, et al.
Molecular Carcinogenesis|March 23, 2021
N<sup>6</sup> -Methyladenosine (m<sup>6</sup> A) readers are dysregulated in renal cell carcinomaFelix von Hagen, Larissa Gundert, Alexander Strick, et al.
Trends in Parasitology|September 4, 2025
Mansonella perstans - the forgotten filariaManuel Ritter, Hsun Yun Hsu, Benjamin Lenz, et al.
Urologic Oncology|May 21, 2020
The contrasting roles of Dysferlin during tumor progression in renal cell carcinomaAlexander Cox, Chenming Zhao, Yuri Tolkach, et al.
European Urology|September 30, 2019
Multiparametric Cystoscopy for Detection of Bladder Cancer Using Real-time Multispectral ImagingMaximilian C Kriegmair, Jan Rother, Bartłomiej Grychtol, et al.
Pageof 20